IFITM3 Inhibits SARS-CoV-2 Infection and Is Associated with COVID-19 Susceptibility

Area of Science:

• Virology
• Immunology
• Genetics

Background:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a significant global public health risk.
• COVID-19 presents with a wide spectrum of illness, from asymptomatic cases to severe pneumonia and death.
• Genetic polymorphisms are hypothesized to influence the diverse clinical presentations of SARS-CoV-2 infection.

Purpose of the Study:

• To investigate the role of the interferon-induced antiviral factor IFITM3 in SARS-CoV-2 infection.
• To determine if genetic variations in IFITM3 are associated with COVID-19 susceptibility.

Main Methods:

• Investigated the mechanism by which IFITM3 affects SARS-CoV-2 entry and cell fusion.
• Analyzed a cohort of Chinese COVID-19 patients to assess the association between IFITM3 genotypes and infection risk.

Main Results:

• IFITM3 was found to inhibit SARS-CoV-2 infection by blocking virus entry mediated by the spike protein and preventing cell-to-cell fusion.
• The rs12252 CC genotype of IFITM3 was significantly associated with an increased risk of SARS-CoV-2 infection in the Chinese patient cohort.

Conclusions:

• IFITM3 plays a crucial role in restricting SARS-CoV-2 infection.
• Individuals with the rs12252 C allele in the IFITM3 gene may be more vulnerable to SARS-CoV-2 infection.
• These findings suggest potential genetic markers for identifying individuals at higher risk for COVID-19, warranting early medical intervention.